Monique van Dijken Eeuwijk's Insider Trades & SAST Disclosures
Monique van Dijken Eeuwijk's most recent trade in Core Laboratories N.V. was a trade of 5,485 Restricted Shares done . Disclosure was reported to the exchange on April 1, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Monique van Dijken Eeuwijk.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Core Laboratories N.V. | Monique van Dijken Eeuwijk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 5,485 | 5,485 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Monique van Dijken Eeuwijk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 5,485 | 17,118 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Monique van Dijken Eeuwijk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 5,485 | 5,485 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Monique van Dijken Eeuwijk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 4,307 | 0 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Monique van Dijken Eeuwijk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 4,307 | 11,633 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Monique van Dijken Eeuwijk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 14,507 | 14,507 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Monique van Dijken Eeuwijk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 14,507 | 0 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Monique van Dijken Eeuwijk | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.10 per share. | 01 Apr 2021 | 7,181 | 7,326 (0%) | 0% | 30.1 | 216,148 | Common Shares |
| Core Laboratories N.V. | Monique van Dijken Eeuwijk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 4,307 | 4,307 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Monique van Dijken Eeuwijk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 14,507 | 14,507 | - | - | Restricted Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges